Weight-based combination therapy with peginterferon alpha-2b and ribavirin for Naïve, relapser and non-responder patients with chronic hepatitis C-Reference-Cited by-同舟云学术

Weight-based combination therapy with peginterferon alpha-2b and ribavirin for Naïve, relapser and non-responder patients with chronic hepatitis C

Published:2006-10 Issue:5 Volume:10 Page:
ISSN:1413-8670
Container-title:Brazilian Journal of Infectious Diseases
language:en
Short-container-title:Braz J Infect Dis

Author:

Gonçales Jr. Fernando Lopes,Vigani Aline,Gonçales Neiva,Barone Antonio Alci,Araújo Evaldo,Focaccia Roberto,Oliveira Umbeliana,Coelho Henrique Sérgio Morais,Paixao Jacqueline,Perez Renata,Lobato Cirley,Weirich Judith,Rosa Heitor,Borges Andrelina,Vila Ricardo,Corrêa-Giannella Maria Lúcia,Ferraz Maria Lúcia Gomes

Publisher

FapUNIFESP (SciELO)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://www.scielo.br/pdf/bjid/v10n5/a02v10n5.pdf

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Boceprevir With Peginterferon Alfa-2a–Ribavirin Is Effective for Previously Treated Chronic Hepatitis C Genotype 1 Infection;Clinical Gastroenterology and Hepatology;2013-01

2. Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3;The Brazilian Journal of Infectious Diseases;2012-05

3. Assessment of the treatment of chronic hepatitis C in the state of Mato Grosso, central Brazil;Memórias do Instituto Oswaldo Cruz;2012-03

4. Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis;Bulletin of the World Health Organization;2012-02-03

5. Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?;BMC Infectious Diseases;2010-07-20